囊胚移植与卵裂期胚胎移植后产科和围产结局比较:系统综述与荟萃分析
该系统综述与荟萃分析纳入12项观察性研究共195325例单胎妊娠,比较囊胚移植与卵裂期胚胎移植的围产结局,未纳入报告相关结局的随机对照试验。囊胚移植与早产、极早产、大于胎龄儿和围产期死亡风险增加相关,与小胎龄儿和消失双胎风险降低相关,但证据质量低或极低。
要点
- 囊胚移植与早产(<37周)、极早产(<32周)、大于胎龄儿和围产期死亡风险增加相关。
- 囊胚移植与小胎龄儿和消失双胎风险降低相关。
- 由于证据质量低或极低,囊胚移植与卵裂期移植的临床均势仍然存在。
核心结论
- 囊胚移植与卵裂期胚胎移植的临床均势仍然存在,因为关联囊胚移植与某些不良围产结局的证据质量低或极低。
研究设计与样本
- 系统综述与荟萃分析,纳入报告单胎妊娠围产结局的随机对照试验和观察性研究,最终纳入12项观察性研究共195325例单胎妊娠,无随机对照试验报告所研究结局。
- 最后电子检索于2016年3月11日进行。
- 纳入研究质量按纽卡斯尔-渥太华量表评估,证据质量按GRADE标准评估。
主要发现
- 囊胚期移植与早产(<37周)、极早产(<32周)、大于胎龄儿和围产期死亡风险增加相关,其中围产期死亡仅来自一项研究。
- 囊胚期移植与小胎龄儿和消失双胎风险降低相关,其中消失双胎仅来自一项研究。
临床怎么用
- 由于现有证据总体质量低,卵裂期与囊胚移植之间的临床均势仍然存在。
- 需要更多大型且实施良好的研究来阐明囊胚移植的潜在风险与获益。
局限性
- 纳入研究的观察性性质以及分析中的一些不一致性和不精确性降低了对估计值的信心。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is blastocyst transfer safe when compared to cleavage stage embryo transfer regarding obstetric and perinatal outcomes? SUMMARY ANSWER: The clinical equipoise between blastocyst and cleavage stage embryo transfer remains as the evidence associating blastocyst transfer with some adverse perinatal outcomes is of low/very low quality. WHAT IS KNOWN ALREADY: Extended embryo culture to the blastocyst stage provides some theoretical advantages and disadvantages. While it permits embryo self-selection, it also exposes those embryos to possible harm due to the in vitro environment. Both effectiveness and safety should be weighed to permit evidence-based decisions in clinical practice. STUDY DESIGN, SIZE, DURATION: This is a systematic review and meta-analysis of randomized controlled trials (RCTs) and observational studies reporting perinatal outcomes for singletons comparing the deliveries resulting from blastocyst and cleavage stage embryo transfer. Observational studies were included because the primary outcomes, perinatal mortality and birth defects, are rare and require a large number of participants (>50 000) to be properly assessed. The last electronic searches were last run on 11 March 2016. PARTICIPANTS/MATERIALS, SETTING, METHOD: There were 12 observational studies encompassing 195 325 singleton pregnancies included in the study. No RCT reported the studied outcomes. The quality of the included studies was evaluated according to the Newcastle-Ottawa Scale and the quality of the evidence was evaluated according to GRADE criteria. MAIN RESULTS AND THE ROLE OF CHANCE: Blastocyst stage transfer was associated with increased risks of preterm birth (<37 weeks), very preterm birth (<32 weeks), large for gestational age and perinatal mortality, although the latter was only identified from one study. Conversely, blastocyst stage transfer was associated with a decrease in the risks of small for gestational age and vanishing twins, although the latter was reported by only one study. LIMITATIONS, REASONS FOR CAUTION: The observational nature of the included studies and some inconsistency and imprecision in the analysis contributed to decreasing our confidence in the estimates. WIDER IMPLICATIONS OF THE FINDINGS: Due to the overall low quality of available evidence, the clinical equipoise between cleavage stage and blastocyst transfer remains. More large well-conducted studies are needed to clarify the potential risks and benefits of blastocyst transfer. As this review was initiated to support global recommendations on best practice, and in light of the challenges in lower resource settings to offer extended culture to blastocyst stage, it is critical to take into consideration these obstetric and neonatal outcomes in order to ensure any recommendation will not result in the overburdening of existing maternal and child health care systems and services. STUDY FUNDING/COMPETING INTERESTS: No external funding was either sought or obtained for this study. The authors have no competing interests to declare. PROSPERO REGISTRATION NUMBER: CRD42015023910.
引用
- Martins WP, Nastri CO, Rienzi L, et al. Obstetrical and perinatal outcomes following blastocyst transfer compared to cleavage transfer: a systematic review and meta-analysis. Hum Reprod. 2016. PMID: 27907898
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。